Becton Dickinson (BDX) Net Income towards Common Stockholders (2009 - 2026)

Becton Dickinson's (BDX) quarterly Net Income towards Common Stockholders came in at -$274.0 million in Q1 2026, down 282.67% year-on-year from $150.0 million in Q1 2025, and down 171.73% on a QoQ basis from $382.0 million in Q4 2025.

Becton Dickinson (BDX) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

Becton Dickinson (BDX) has 18 years of Net Income towards Common Stockholders data on file, last reported at -$274.0 million in Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders fell 282.67% year-over-year to -$274.0 million in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 12.31% decrease from a year earlier, with the FY2025 full-year figure at $1.7 billion, down 1.58% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at -$274.0 million, down from $382.0 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for BDX reached as high as $574.0 million in Q2 2025 and fell as low as -$274.0 million in Q1 2026.
  • Historically, Net Income towards Common Stockholders has averaged $340.6 million across 5 years, with a median of $392.0 million in 2023.
  • Across the five-year window, Net Income towards Common Stockholders soared 270.37% in 2024 and sank 282.67% in 2026, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at $486.0 million in 2022, then slumped by 42.18% to $281.0 million in 2023, then gained by 7.83% to $303.0 million in 2024, then advanced by 26.07% to $382.0 million in 2025, then plunged by 171.73% to -$274.0 million in 2026.
  • Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$274.0 million in Q1 2026, $382.0 million in Q4 2025, and $493.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 22.13 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 823.20 Mn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -274.00 Mn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 239.00 Mn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 398.73 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 147.90 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -77.90 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 13.00 Mn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 112.77 Mn
10 Baxter International 11.17 Bn 9.12 Bn 891.00 Mn 2.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -274.00 Mn
Dec 31, 2025 382.00 Mn
Sep 30, 2025 493.00 Mn
Jun 30, 2025 574.00 Mn
Mar 31, 2025 150.00 Mn
Dec 31, 2024 303.00 Mn
Sep 30, 2024 400.00 Mn
Jun 30, 2024 487.00 Mn
Mar 31, 2024 537.00 Mn
Dec 31, 2023 281.00 Mn
Sep 30, 2023 108.00 Mn
Jun 30, 2023 392.00 Mn
Mar 31, 2023 438.00 Mn
Dec 31, 2022 486.00 Mn
Sep 30, 2022 265.00 Mn
Jun 30, 2022 338.00 Mn
Mar 31, 2022 431.00 Mn
Dec 31, 2021 655.00 Mn
Sep 30, 2021 242.00 Mn
Jun 30, 2021 502.00 Mn